The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Corporate Authors:
      Quality of Life in Kids: Key evidence to strengthen decisions in Australia (QUOKKA) Project team
    • Source:
      Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
    • Publication Information:
      Publication: Auckland : Adis, Springer International
      Original Publication: Auckland ; Philadelphia : Adis International, c1992-
    • Subject Terms:
      Quality of Life* ; Parents* ; COVID-19* ; Health Status*; Humans ; Male ; Female ; Child ; Surveys and Questionnaires ; Australia ; Reproducibility of Results ; Adult ; Adolescent ; Child Health ; Child, Preschool ; Caregivers ; Psychometrics
    • Abstract:
      Background:  The EuroQol Health and Wellbeing Short Version (EQ-HWB-S) instrument has been developed to measure the health and wellbeing of care-recipients and their caregivers for use in economic evaluation.The EQ-HWB-S has nine items, and pilot UK preference weights have now been developed.
      Objective: We aimed to investigate the validity of the instrument in parents of children with and without health conditions.
      Methods: EQ-HWB-S data were sourced from an Australian paediatric multi-instrument comparison study. We analysed the baseline characteristics and response distribution of the EQ-HWB-S items. Assessment of known-group validity was conducted for EQ-HWB-S items, level sum-scores and preference-weighted scores, including partial effects. Known-group analyses included three child health variables and where caregivers reported coronavirus disease 2019 (COVID-19) had impacted their wellbeing. We included analyses across gender, controlled for child and parent demographic variables, and compared scores across child health conditions.
      Results:  Item responses were distributed as expected, with higher skew for mobility and activities. Parents experienced high levels of exhaustion. We detected significant differences between groups for level sum-scores and preference-weighted scores, as hypothesised; all tests were significant (p < 0.001), with moderate effect sizes (effect sizes were slightly higher for female than male parents). The regression analysis identified significantly different EQ-HWB-S scores for child health samples compared with the general population after controlling for demographic variables. Differences were observed between child health conditions.
      Conclusion: The EQ-HWB-S is a useful instrument to measure parent quality of life for economic evaluation in this population. Data were limited to one time point; further research should investigate the instrument's sensitivity to change and test-retest reliability in this population.
      (© 2024. The Author(s).)
    • References:
      Soc Sci Med. 1991;32(11):1291-6. (PMID: 2068612)
      Pharmacoeconomics. 2019 Apr;37(4):475-499. (PMID: 30887469)
      Front Psychol. 2017 Feb 09;8:163. (PMID: 28232811)
      Children (Basel). 2021 Aug 20;8(8):. (PMID: 34438605)
      Ambul Pediatr. 2002 Jan-Feb;2(1):38-48. (PMID: 11888437)
      Value Health. 2022 Apr;25(4):512-524. (PMID: 35227597)
      Value Health. 2022 Apr;25(4):525-533. (PMID: 35365299)
      Qual Life Res. 2022 Jul;31(7):2167-2173. (PMID: 35247152)
      J Autism Dev Disord. 2014 Dec;44(12):3185-203. (PMID: 25022253)
      Asian J Psychiatr. 2016 Oct;23:71-77. (PMID: 27969083)
      Autism. 2013 Jul;17(4):465-80. (PMID: 21788255)
      Value Health. 2023 Jul;26(7):1073-1084. (PMID: 36805577)
      Lancet Public Health. 2022 Sep;7(9):e775-e786. (PMID: 36057276)
      Value Health. 2022 Apr;25(4):534-543. (PMID: 35279371)
      Med J Aust. 2020 Feb;212(2):57-62.e1. (PMID: 31760662)
      Med Decis Making. 2015 Jan;35(1):81-93. (PMID: 25057048)
      Health Qual Life Outcomes. 2013 Oct 21;11:173. (PMID: 24139439)
      J Child Fam Stud. 2022;31(3):881-895. (PMID: 35039741)
      Eur J Health Econ. 2021 Sep;22(7):1067-1081. (PMID: 33909157)
      J Health Econ. 2002 Mar;21(2):271-92. (PMID: 11939242)
      BMJ. 2021 Aug 31;374:n1972. (PMID: 34465574)
      Value Health. 2022 Apr;25(4):492-511. (PMID: 35365298)
      Value Health. 2022 Apr;25(4):482-491. (PMID: 35277337)
      Pharmacoeconomics. 2019 Apr;37(4):451-456. (PMID: 30328563)
      Soc Sci Med. 2021 Jun;279:113996. (PMID: 33993007)
      Acta Paediatr. 2010 Mar;99(3):427-32. (PMID: 19912139)
      Qual Life Res. 2020 Sep;29(9):2445-2454. (PMID: 32266555)
      Soc Work Health Care. 2001;34(3-4):299-314. (PMID: 12243430)
    • Grant Information:
      APP1200816 MRFF
    • Publication Date:
      Date Created: 20240118 Date Completed: 20240612 Latest Revision: 20240615
    • Publication Date:
      20240615
    • Accession Number:
      PMC11168993
    • Accession Number:
      10.1007/s40273-024-01351-5
    • Accession Number:
      38238605